Global CRISPR Genome Editing Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 CRISPR Genome Editing Market Overview

• 1.1 Product Overview and Scope of CRISPR Genome Editing
• 1.2 Classification of CRISPR Genome Editing by Types
  • 1.2.1 Global CRISPR Genome Editing Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global CRISPR Genome Editing Revenue Market Share by Types in 2018
  • 1.2.3 Genetic Engineering
  • 1.2.4 Gene Library
  • 1.2.5 Human Stem Cells
  • 1.2.6 Others
• 1.3 Global CRISPR Genome Editing Market by Application
  • 1.3.1 Global CRISPR Genome Editing Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Biotechnology Companies
  • 1.3.3 Pharmaceutical Companies
  • 1.3.4 Others
• 1.4 Global CRISPR Genome Editing Market by Regions
  • 1.4.1 Global CRISPR Genome Editing Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) CRISPR Genome Editing Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) CRISPR Genome Editing Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CRISPR Genome Editing Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) CRISPR Genome Editing Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CRISPR Genome Editing Status and Prospect (2014-2024)
• 1.5 Global Market Size of CRISPR Genome Editing (2014-2024)

2 Manufacturers Profiles

• 2.1 Editas Medicine
  • 2.1.1 Business Overview
  • 2.1.2 CRISPR Genome Editing Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Editas Medicine CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 CRISPR Therapeutics
  • 2.2.1 Business Overview
  • 2.2.2 CRISPR Genome Editing Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 CRISPR Therapeutics CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Horizon Discovery
  • 2.3.1 Business Overview
  • 2.3.2 CRISPR Genome Editing Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Horizon Discovery CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Sigma-Aldrich
  • 2.4.1 Business Overview
  • 2.4.2 CRISPR Genome Editing Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Sigma-Aldrich CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Genscript
  • 2.5.1 Business Overview
  • 2.5.2 CRISPR Genome Editing Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Genscript CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Sangamo Biosciences
  • 2.6.1 Business Overview
  • 2.6.2 CRISPR Genome Editing Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Sangamo Biosciences CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Lonza Group
  • 2.7.1 Business Overview
  • 2.7.2 CRISPR Genome Editing Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Lonza Group CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Integrated DNA Technologies
  • 2.8.1 Business Overview
  • 2.8.2 CRISPR Genome Editing Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Integrated DNA Technologies CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 New England Biolabs
  • 2.9.1 Business Overview
  • 2.9.2 CRISPR Genome Editing Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 New England Biolabs CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Origene Technologies
  • 2.10.1 Business Overview
  • 2.10.2 CRISPR Genome Editing Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Origene Technologies CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Transposagen Biopharmaceuticals
  • 2.11.1 Business Overview
  • 2.11.2 CRISPR Genome Editing Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Transposagen Biopharmaceuticals CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Thermo Fisher Scientific
  • 2.12.1 Business Overview
  • 2.12.2 CRISPR Genome Editing Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Thermo Fisher Scientific CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Caribou Biosciences
  • 2.13.1 Business Overview
  • 2.13.2 CRISPR Genome Editing Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Caribou Biosciences CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Precision Biosciences
  • 2.14.1 Business Overview
  • 2.14.2 CRISPR Genome Editing Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Precision Biosciences CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Cellectis
  • 2.15.1 Business Overview
  • 2.15.2 CRISPR Genome Editing Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Cellectis CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 Intellia Therapeutics
  • 2.16.1 Business Overview
  • 2.16.2 CRISPR Genome Editing Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 Intellia Therapeutics CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)

3 Global CRISPR Genome Editing Market Competition, by Players

• 3.1 Global CRISPR Genome Editing Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 CRISPR Genome Editing Players Market Share
  • 3.2.2 Top 10 CRISPR Genome Editing Players Market Share
• 3.3 Market Competition Trend

4 Global CRISPR Genome Editing Market Size by Regions

• 4.1 Global CRISPR Genome Editing Revenue and Market Share by Regions
• 4.2 North America CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 4.3 Europe CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 4.5 South America CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa CRISPR Genome Editing Revenue and Growth Rate (2014-2019)

5 North America CRISPR Genome Editing Revenue by Countries

• 5.1 North America CRISPR Genome Editing Revenue by Countries (2014-2019)
• 5.2 USA CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 5.3 Canada CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 5.4 Mexico CRISPR Genome Editing Revenue and Growth Rate (2014-2019)

6 Europe CRISPR Genome Editing Revenue by Countries

• 6.1 Europe CRISPR Genome Editing Revenue by Countries (2014-2019)
• 6.2 Germany CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 6.3 UK CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 6.4 France CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 6.5 Russia CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 6.6 Italy CRISPR Genome Editing Revenue and Growth Rate (2014-2019)

7 Asia-Pacific CRISPR Genome Editing Revenue by Countries

• 7.1 Asia-Pacific CRISPR Genome Editing Revenue by Countries (2014-2019)
• 7.2 China CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 7.3 Japan CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 7.4 Korea CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 7.5 India CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia CRISPR Genome Editing Revenue and Growth Rate (2014-2019)

8 South America CRISPR Genome Editing Revenue by Countries

• 8.1 South America CRISPR Genome Editing Revenue by Countries (2014-2019)
• 8.2 Brazil CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 8.3 Argentina CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 8.4 Colombia CRISPR Genome Editing Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue CRISPR Genome Editing by Countries

• 9.1 Middle East and Africa CRISPR Genome Editing Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 9.3 UAE CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 9.4 Egypt CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
• 9.6 South Africa CRISPR Genome Editing Revenue and Growth Rate (2014-2019)

10 Global CRISPR Genome Editing Market Segment by Type

• 10.1 Global CRISPR Genome Editing Revenue and Market Share by Type (2014-2019)
• 10.2 Global CRISPR Genome Editing Market Forecast by Type (2019-2024)
• 10.3 Genetic Engineering Revenue Growth Rate (2014-2024)
• 10.4 Gene Library Revenue Growth Rate (2014-2024)
• 10.5 Human Stem Cells Revenue Growth Rate (2014-2024)
• 10.6 Others Revenue Growth Rate (2014-2024)

11 Global CRISPR Genome Editing Market Segment by Application

• 11.1 Global CRISPR Genome Editing Revenue Market Share by Application (2014-2019)
• 11.2 CRISPR Genome Editing Market Forecast by Application (2019-2024)
• 11.3 Biotechnology Companies Revenue Growth (2014-2019)
• 11.4 Pharmaceutical Companies Revenue Growth (2014-2019)
• 11.5 Others Revenue Growth (2014-2019)

12 Global CRISPR Genome Editing Market Size Forecast (2019-2024)

• 12.1 Global CRISPR Genome Editing Market Size Forecast (2019-2024)
• 12.2 Global CRISPR Genome Editing Market Forecast by Regions (2019-2024)
• 12.3 North America CRISPR Genome Editing Revenue Market Forecast (2019-2024)
• 12.4 Europe CRISPR Genome Editing Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific CRISPR Genome Editing Revenue Market Forecast (2019-2024)
• 12.6 South America CRISPR Genome Editing Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa CRISPR Genome Editing Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology